Skip to content

Detection and Automatic Segmentation of Liver Nodules in Patients With Colorectal Adenocarcinoma

Detection and Automatic Segmentation of Liver Nodules in Patients With Colorectal

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04834596
Acronym
OOPS
Enrollment
300
Registered
2021-04-08
Start date
2021-05-02
Completion date
2022-05-02
Last updated
2021-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Detection of Liver Metastases

Brief summary

Evaluation of the diagnostic performance of artificial intelligence-based software for the detection of liver nodules on scanner in patients at risk of liver metastases of colorectal cancer

Detailed description

The aim of this study is to evaluate the performance of a software for liver nodule detection in patients with colorectal cancer compared to the consensus of two radiologists analysis. 300 hepatic scanners will be analysed.

Interventions

OTHERretrospectives analysis on hepatic scanner

hepatic scanner will be analysed by two radiologist and by the software

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients consecutively treated for colorectal cancer a * Availability of imaging by injected abdominal scanner including at least one portal phase * Age over 18

Exclusion criteria

* Patients with treatment of the hepatic nodule by ablation or previous hepatic surgery * Imaging follow-up \<12 months * Non-interpretable scanner (artefact, injection quality, etc.) * Patients with more than 10 liver metastases

Design outcomes

Primary

MeasureTime frameDescription
To evaluate the performance of the software for detection of hepatic nodules on CT scan of patients with colorectal cancer compared to a reference constituted by the evaluation established by two radiologists in consensus.1 monthNumber of nodules detected by the software compared to the reference method

Countries

France

Contacts

Primary ContactMarie Bost
mabost@chu-angers.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026